Bio­Cen­triq names ex-Re­silient ex­ec as new CEO; Sanofi, As­traZeneca boost Bey­for­tus pro­duc­tion

Wel­come to End­points News’ man­u­fac­tur­ing briefs, where we bring you es­sen­tial news on new builds, col­lab­o­ra­tions, re­calls and more.

Cell ther­a­py CD­MO Bio­Cen­triq has …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER